Principal Investigator
Bernard Baumel
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20251381
Clinical Trial Summary
A Pilot Study to Assess the Effect of Adding 1 Infusion of Human Mesenchymal Stem Cells (hMSC) to Patients treated with Anti-Amyloid Monoclonal Antibodies who are suffering from Mild Cognitive Impairment or mild Alzheimers Disease.
Phase
TBD
Funding Agency/Sponsor
Intramural
Disease
Other